Treatment of circadian rhythm disorders

Use of an effective amount of tasimelteon to treat or entrain a light perception impaired patient suffering from Non-24 hour disorder. A medicament containing Tasimelteon is used to entrain the patient to a 24 hour sleep-wake cycle in which the patient awakens at or near a target wake time following...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dressman, Marlene, Polymeropoulos, Mihael, Feeney, John, Licamele, Louis
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of an effective amount of tasimelteon to treat or entrain a light perception impaired patient suffering from Non-24 hour disorder. A medicament containing Tasimelteon is used to entrain the patient to a 24 hour sleep-wake cycle in which the patient awakens at or near a target wake time following a daily sleep period of approximately 7 to 9 hours, and maintaining this 24 hour sleep-wake cycle. The medicament is formulated for oral administration of 20 -50 mg of tasimelteon once daily to the patient 0.5 to 1.5 hours before a target bedtime.